β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
about
Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot StudyAssessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patientsContinuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model.Assays for determination of ertapenem for applications in therapeutic drug monitoring, pharmacokinetics and sample stability.Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.Approaches for dosage individualisation in critically ill patients.Antimicrobial stewardship of β-lactams in intensive care units.Treatment option for sepsis in children in the era of antibiotic resistance.Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.Effect of blood protein concentrations on drug-dosing regimes: practical guidance.Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?[Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?]Penicillin G Treatment in Infective Endocarditis Patients - Does Standard Dosing Result in Therapeutic Plasma Concentrations?An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet DetIs there a role for continuous infusion of β-lactam antibiotics in severe sepsis?Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit.[Bacterial sepsis : Diagnostics and calculated antibiotic therapy].Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients.Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment.Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
P2860
Q28551453-093D4AAC-8A67-4DCA-81BA-FE441ACB88CDQ33552161-F91A88D9-7B9A-4DF8-AC40-8E201DAF7D0CQ34923002-3804B5E9-4715-40DE-BE10-463A450DC216Q35218071-89D9E6F9-C15C-4239-9EAC-CDAF8AD9CE0CQ36158212-401849D5-F6A3-439B-AC0D-48469AF1932EQ37335840-7A699C3A-3406-4224-83E1-018AC8989C0BQ38100704-B86E1353-F5DA-43CA-B201-7976E0E78DD8Q38125209-4B4AAAD1-EDC7-427B-BAF7-48E82175ED9CQ38198157-2944664B-36F8-4433-A605-0E581BBA1D27Q38246118-84173263-00D5-4513-ABB9-69502F9B1BC7Q38884589-5EDC159B-C3EC-4D28-80FF-C9B1D8EE18E8Q39219941-3FB8DF9A-B18A-40AA-B35F-99DDF50C721EQ39344408-4472A10A-C2F2-4273-A038-8101893C07D1Q40541397-D5B0E619-574D-4B98-86E1-3D622AECF2D8Q40561933-44EB3CF1-FEDE-4B65-97D4-E9EE891A88C6Q42232248-238C6879-95A2-47C0-B61D-939EB3CFCEC1Q42236097-917C237E-FA2B-41F4-961B-142AFAC602F5Q42407649-98C2B776-5023-4BB1-96EB-C5B3BB8DE952Q42751350-FA2DC45B-BE97-4AE4-B034-E050FF677AE1Q48562663-7533E909-1A02-4D49-AFEF-DA94EEEC37E6Q49589601-FE2BFC51-55AE-4DC8-8574-99DA55B5114AQ51121630-37C39336-66D5-4F34-9B01-6F657B0EC770Q54257517-824DBD0C-B0F9-4D8E-9A59-3EABCB4806DEQ58701649-4BFC7E84-9BB8-48E6-A585-C5AC78CF1989
P2860
β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
β-Lactam therapeutic drug moni ...... function and hypoalbuminaemia.
@en
β-Lactam therapeutic drug moni ...... function and hypoalbuminaemia.
@nl
type
label
β-Lactam therapeutic drug moni ...... function and hypoalbuminaemia.
@en
β-Lactam therapeutic drug moni ...... function and hypoalbuminaemia.
@nl
prefLabel
β-Lactam therapeutic drug moni ...... function and hypoalbuminaemia.
@en
β-Lactam therapeutic drug moni ...... function and hypoalbuminaemia.
@nl
P2093
P50
P1476
β-Lactam therapeutic drug moni ...... function and hypoalbuminaemia.
@en
P2093
Brett McWhinney
Karin Lust
Yoshiro Hayashi
P304
P356
10.1016/J.IJANTIMICAG.2012.10.002
P577
2012-11-13T00:00:00Z